The company reports that NUOS 3 can enable patients who have been declared clinically dead — at times for over 30 minutes — and later resuscitated to regain the ability to communicate. Despite ...

ElectroCore (Nasdaq:ECOR) announced today that it completed its previously announced acquisition of NeuroMetrix  (Nasdaq:NURO ...

Rhythm Technologies (Nasdaq: IRTC) shares are on the rise on first-quarter results that were mixed compared to the Wall ...

Aktiia announced today that it raised an oversubscribed $42 million Series B funding round and introduced its new "Hilo" ...

The Financial Times reports today that histotripsy tech developer HistoSonics is considering a potential sale after receiving ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

Stryker reported Street-beating financial results and upped its sales forecast, but said tariffs will decrease previously ...

Baxter Chair and interim CEO Brent Shafer said some tariff mitigation activities are underway while others are being ...

CEO Jason Hollar said Cardinal Health is "engaging" with the Trump Administration "to try to mitigate impact to patient care.

Element Science announced today that it received FDA pre-market approval for its Jewel patch wearable cardioverter ...

Intuitive (NASDAQ: ISRG) announced today that it received FDA clearance for a new indication for its da Vinci single port (SP ...